LOGO
LOGO

health news

  • Vanda Pharmaceuticals Submits Imsidolimab BLA To FDA, Stock Gains In Pre-Market December 15, 2025 07:57 ET

    Vanda Pharmaceuticals Inc. (VNDA), Monday announced that the company has submitted a Biologics License Application or BLA to the U.S. Food and Drug Administration for imsidolimab to treat generalized pustular psoriasis, a rare, chronic autoinflammatory skin disorder. The application is backed by positive...

  • hepatitisbvaccine 12122025 lg US Panel Drops Longstanding Newborn Hepatitis B Shot Recommendation December 12, 2025 16:14 ET

    A federal vaccine advisory committee has decided to stop recommending hepatitis B vaccinations for all newborns, marking a significant change from the U.S. public health policy that's been in place for decades.

  • fda 12122025 lg US FDA Considers Adding Black Box Warning On COVID-19 Vaccines : Report December 12, 2025 12:00 ET

    The U.S. Food and Drug Administration (FDA) is considering adding a "black box" warning, its strongest type of safety alert, to COVID-19 vaccines, according to a CNN report. It further noted that the idea is being pushed by Vinay Prasad, the FDA's top vaccine official. Notably, a black box warning...

  • Cytokinetics Receives CHMP's Positive Opinion On MYQORZO December 12, 2025 11:03 ET

    Cytokinetics, Inc. (CYTK), Friday announced that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorization for MYQORZO, also known as aficamten, in the European Union for the patients with symptomatic...

  • sunscreen 12122025 lg FDA Proposes To Add Bemotrizinol As Sunscreen Active Ingredient December 12, 2025 07:23 ET

    The U.S. Food and Drug Administration has announced that it is taking action to advance sunscreen innovation, part of a broader initiative in the Office of Nonprescription Drugs. The agency is proposing to add bemotrizinol as a permitted active ingredient for use in sunscreens. Based on the data...

  • vaccine 12122025 lg WHO Experts Rule Out Link Between Vaccines And Autism December 12, 2025 07:09 ET

    New analysis from the World Health Organization's global expert committee on vaccine safety has found that, based on available evidence, there is no link between vaccines and autism spectrum disorders, or ASD. The conclusion reaffirms WHO's position that childhood vaccines do not cause autism. The...

  • measles 11122025 lg Low Vaccination Rates Fuel Measles Outbreak In South Carolina December 11, 2025 15:41 ET

    Health officials in South Carolina shared that the measles outbreak in the state is getting worse, with no signs of slowing down after Thanksgiving and other large gatherings. As of Wednesday, 111 cases have been reported in the upstate region, which includes Greenville and Spartanburg, with 27 new...

  • genetic 11122025 lg Study Reveals Shared Genetic Roots Behind Multiple Psychiatric Disorders December 11, 2025 13:13 ET

    Researchers from around the world have found new clues about why many people have more than one psychiatric disorder at the same time. In a large study, published in Nature, they examined the shared genetic roots of 14 mental health conditions, including depression, anxiety, schizophrenia, bipolar...

  • AC Immune Announces Positive Interim Data From Phase 2 ACI-7104.056 Trial December 11, 2025 08:01 ET

    AC Immune SA (ACIU), Thursday announced positive interim safety and efficacy results from the Phase 2 VacSYn trial of anti-alpha-synuclein active immunotherapy ACI-7104.056 in early Parkinson's disease. The findings noted that ACI-7104.056 induced a robust antibody response against the immunizing...

  • byheart 11122025 lg CDC Warns Parents Against Using ByHeart Whole Nutrition Infant Formula December 11, 2025 07:28 ET

    The Centers for Disease Control and Prevention has urged parents to stop using any ByHeart Whole Nutrition infant formula immediately, even if it is mistakenly found for sale in stores or online. Laboratory tests have shown that the formula is contaminated with botulism spores and can make infants...

  • covid 10122025 lg Vaccinated Adults In France Show Lower Mortality, Study Finds December 10, 2025 15:31 ET

    A large study covering nearly half of France's population found that young and middle-aged adults who received mRNA COVID-19 vaccines were 74 percent less likely to die from COVID-19 than those who were not vaccinated. Surprisingly, vaccinated people were also 25 percent less likely to die from any cause...

  • social 10122025 lg Study Links Heavy Social Media Use To Rising Attention Problems In Children December 10, 2025 13:34 ET

    A new study revealed that children who spend a lot of time on social media may have more trouble concentrating and could be more likely to develop symptoms of ADHD. Researchers from the Karolinska Institutet followed more than 8,000 U.S. children from ages 9-10 to 14. The children reported how much...

  • euwho 10122025 lg EU-WHO Tie Up To Enhance Antimicrobial Resistance Response December 10, 2025 05:59 ET

    The European Commission and the World Health Organization have signed a 3.5 million EURO agreement under the EU4Health program to strengthen the global response to antimicrobial resistance. This partnership will support the WHO in monitoring the development of antimicrobials and medical countermeasures,...

  • fdagenetherapy 10122025 lg FDA Approves First Gene Therapy Treatment For Rare Immune Disorder Wiskott-Aldrich Syndrome December 10, 2025 05:52 ET

    The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for the treatment of a rare, genetic immune disorder Wiskott-Aldrich syndrome, or WAS. Waskyra is indicated for pediatric patients six months and older and adults with WAS who...

  • fdadrug 10122025 lg FDA Approves First Drug Under Program To Strengthen US Antibiotic Manufacturing December 10, 2025 04:19 ET

    The U.S. Food and Drug Administration has approved Augmentin XR (amoxicillin-clavulanate potassium) under the Commissioner's National Priority Voucher pilot program, marking the first approval achieved through this review pathway. The approval was completed in just two months, representing a major reduction of the review timeline for this type of application. "Over the last few decades, America l

Global Economics Weekly Update - December 15-19, 2025

December 19, 2025 15:10 ET
U.S. inflation data and interest rate decisions by major central banks were the highlights of this busy week for economics news flow. Employment data and survey results on the housing markets also gained attention in the U.S. In Europe, the European Central Bank and Bank of England announced their policy decisions and macroeconomic projections.